Nancy M. Laing

发表

Fluoroquinolone-Resistant Urinary Isolates of Escherichia coli from Outpatients Are Frequently Multidrug Resistant: Results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance Study

J. Karlowsky, D. Hoban, G. Zhanel, 2006, Antimicrobial Agents and Chemotherapy.

Antimicrobial susceptibility of Clostridioides difficile isolated from diarrhoeal stool specimens of Canadian patients: summary of results from the Canadian Clostridioides difficile (CAN-DIFF) surveillance study from 2013 to 2017.

J. Karlowsky, H. Adam, M. Baxter, 2020, The Journal of antimicrobial chemotherapy.

PCR ribotyping and antimicrobial susceptibility testing of isolates of Clostridium difficile cultured from toxin-positive diarrheal stools of patients receiving medical care in Canadian hospitals: the Canadian Clostridium difficile Surveillance Study (CAN-DIFF) 2013-2015.

J. Karlowsky, H. Adam, M. Baxter, 2018, Diagnostic microbiology and infectious disease.

In vitro pharmacodynamic modelling simulating free serum concentrations of fluoroquinolones against multidrug-resistant Streptococcus pneumoniae.

D. Hoban, G. Zhanel, Michael Walters, 2001, The Journal of antimicrobial chemotherapy.

Pharmacodynamic activity of garenoxacin against ciprofloxacin-resistant Streptococcus pneumoniae.

D. Hoban, A. Noreddin, G. Zhanel, 2006, The Journal of antimicrobial chemotherapy.

Pharmacodynamic activity of fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae.

D. Hoban, A. Noreddin, K. Nichol, 2002, The Journal of antimicrobial chemotherapy.

Synergy of an Investigational Glycopeptide, LY333328, with Once-Daily Gentamicin against Vancomycin-ResistantEnterococcus faecium in a Multiple-Dose, In Vitro Pharmacodynamic Model

J. Karlowsky, D. Hoban, G. Zhanel, 1999, Antimicrobial Agents and Chemotherapy.

Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).

D. Low, J. Karlowsky, D. Hoban, 2006, International journal of antimicrobial agents.

Antimicrobial-Resistant Pathogens in Intensive Care Units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) Study, 2005-2006

Michael R. Mulvey, M. Mulvey, J. Karlowsky, 2008, Antimicrobial Agents and Chemotherapy.

In Vitro Activity of API-1252, a Novel FabI Inhibitor, against Clinical Isolates of Staphylococcus aureus and Staphylococcus epidermidis

N. Kaplan, J. Karlowsky, D. Hoban, 2007, Antimicrobial Agents and Chemotherapy.

Mutant Prevention Concentrations of Levofloxacin Alone and in Combination with Azithromycin, Ceftazidime, Colistin (Polymyxin E), Meropenem, Piperacillin-Tazobactam, and Tobramycin against Pseudomonas aeruginosa

H. Adam, G. Zhanel, N. Laing, 2006, Antimicrobial Agents and Chemotherapy.

Antimicrobial susceptibility of clinical isolates of Neisseria gonorrhoeae to alternative antimicrobials with therapeutic potential

I. Martin, M. Mulvey, J. Karlowsky, 2017, The Journal of antimicrobial chemotherapy.

Molecular Characterization of Increasing Fluoroquinolone Resistance in Streptococcus pneumoniae Isolates in Canada, 1997 to 2005

C. Hoban, D. Hoban, H. Adam, 2006, Antimicrobial Agents and Chemotherapy.

Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).

L. Nicolle, G. Harding, D. Hoban, 2005, International journal of antimicrobial agents.